Exposure of Sensitive Information to an Unauthorized Actor in DEXMA DEXGate

published 2023-10-19 3 y ago modified 2026-06-17 4 mo ago also EUVD-2023-47098

cvss: 5.3; version 3.1, CNA
cisa kev: Not listed; not in CISA's catalog
epss: 0.5%; EPSS 0.5% chance of exploitation in 30 days, percentile 41%
public exploits: 0; none known

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-23-271-02 updated 2023-09-26 cvss 5.3

DEXMA DexGate

DEXMA DEXGate 20130114
affected: mitigation “Dexma has not responded to CISA's requests to coordinate at this time.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

CISA SSVC

Exploitation: none
Automatable: yes
Technical impact: partial
Assessed: 2 y ago (2024-09-12)

Exploit prediction

0.48% chance of exploitation in the next 30 days, higher than 41% of all scored CVEs (FIRST EPSS, 2026-11-08).

CVSS scores

assigned by	version	score	vector
CNA	3.1	5.3	CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
NVD	3.1	5.3	CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Affected products

DEXMA DexGate

Classification

Weakness

CWE-200 Exposure of Sensitive Information to an Unauthorized Actor

References

cisa.gov /news-events/ics-advisories/icsa-23-271-02
third-party-advisory, us-government-resource

Sources

CVE List CVE-2023-42666
NVD CVE-2023-42666

Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

Summary